gms | German Medical Science

70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

12.05. - 15.05.2019, Würzburg

ePoster Montag, 13.05.2019
Neurochirurgische Onkologie III/Neurosurgical oncology III

Meeting Abstract (P071)

The role of the calpain/calpastatin system in chemoresistance of glioblastoma

Hannen R, Chen Cy, Schilling O, Bartsch JW, Nimsky C
Meeting Abstract (P072)

Decision for extent of surgical resection in elderly glioblastoma

Ahmadipour Y, Müller O, Dammann P, Pierscianek D, Darkwah Oppong M, Grzywotz A, Sure U, Jabbarli R
Meeting Abstract (P073)

The expression of the intercellular communication proteins GAP43 and Cx43 in diffuse and anaplastic gliomas

Krigers A, Moser P, Fritsch H, Thomé C, Freyschlag CF
Meeting Abstract (P074)

The synthetic ligand Apelin-F13A binds and activates glioblastoma APLNR reducing the pro-invasive side effect of anti-angiogenic therapy

Kälin R, Stöcklein V, Li M, Reinhard S, Mastrella G, Wagner E, Tonn JC, Glass R
Meeting Abstract (P075)

Early clinical experience with gliovac (ERC1671) antitumor vaccination therapy for recurrent glioblastoma

Heiland T, Karpel-Massler G, Wirtz CR, Halatsch ME
Meeting Abstract (P076)

Current evidence for the application of blood-based biomarkers in high grade gliomas

Pierscianek D, Ahmadipour Y, Darkwah Oppong M, Rauschenbach L, Michel A, Sure U, Jabbarli R
Meeting Abstract (P077)

Microenvironmental release of CHI3L1 drives transcriptional re-programming and promotes proliferation

Wurm J, Behringer S, Franco P, Beck J, Schnell O, Heiland DH
Meeting Abstract (P078)

Extracellular released glutamate stimulates a proliferative-autocrine-loop in glioblastoma

Garrelfs N, Behringer S, Wurm J, Beck J, Schnell O, Heiland DH
Meeting Abstract (P079)

Effects of protocadherin gamma C3 (PCDHGC3) knockout on proliferation, invasion and self-renewal abilities in glioblastoma cell lines

Kempe CD, Baptista F, Fabregat MC, Li N, Hagemann C, Burek M
Meeting Abstract (P080)

Pro-invasive side effects of bevacizumab and ramucirumab therapy in proneural and classical GBM is mediated by apelin signalling and reducible by apelin receptor blockade

Stöcklein V, Li M, Harter PN, Zdouc N, Mittelbronn M, Tonn JC, Glass R, Kälin R
Meeting Abstract (P081)

Meningeosis neoplastica in patients with high-grade gliomas

Sachkova A, Komboz F, Petrov A, Bock HC, Mielke D, Rohde V, Malinova V
Meeting Abstract (P082)

Interim results from a proof-of-concept clinical trial assessing the safety of the coordinated undermining of survival paths by 9 repurposed drugs (version 3) combined with metronomic temozolomide (CUSP9v3) protocol for recurrent glioblastoma

Halatsch ME, Kast RE, Karpel-Massler G, Schmitz B, Zolk O, Bullinger L, Mayer-Steinacker R, Maier L, Scheuerle A, Mayer B, Schmidt C, Zeiler K, Elshaer Z, Awad F, Panther P, Schmelzle B, Beckers K, Siegelin MD, Westhoff MA, Wirtz CR, Bouche G, Heiland T